Pages that link to "Q73007855"

The following pages link to Living-donor liver transplantation for hepatocellular carcinoma (Q73007855):

Displaying 47 items.

• Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma (Q24540058) (← links)
• Application of contrast-enhanced ultrasound after liver transplantation: Current status and perspectives (Q26773215) (← links)
• Management of HCC (Q28258769) (← links)
• Liver transplantation for malignancy: current treatment strategies and future perspectives (Q33594868) (← links)
• Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience (Q34630506) (← links)
• The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations (Q34826535) (← links)
• Living-donor liver transplantation: 12 years of experience in Asia (Q35067356) (← links)
• Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. (Q35207762) (← links)
• Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes (Q35543614) (← links)
• Role of adult living liver donation in patients with hepatocellular cancer (Q35551277) (← links)
• Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum (Q35824978) (← links)
• Role of liver transplantation for hepatobiliary malignant disorders (Q35853027) (← links)
• Progress in living donor liver transplantation (Q35994608) (← links)
• Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation. (Q37062909) (← links)
• Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation. (Q37302080) (← links)
• Does living donation have advantages over deceased donation in liver transplantation? (Q37794228) (← links)
• Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation. (Q37928952) (← links)
• Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation (Q38474433) (← links)
• Current developments in pediatric liver transplantation (Q38530791) (← links)
• Living related liver transplantation for hepatocellular carcinoma in Egypt. (Q38988733) (← links)
• Using Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation—Interactions Between Calcineurin Inhibitor: Two Case Reports (Q39708412) (← links)
• Historical perspective of living donor liver transplantation (Q40136744) (← links)
• Two rare metachronous metastases of hepatocellular carcinoma after liver transplantation (Q42137887) (← links)
• Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility (Q42617266) (← links)
• The difference and the transition of indication for adult living donor liver transplantation between the West and the East (Q43805781) (← links)
• Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria (Q44037556) (← links)
• Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival (Q45080893) (← links)
• Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan (Q45258006) (← links)
• Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria (Q46041896) (← links)
• Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value. (Q46452996) (← links)
• Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B. (Q46478401) (← links)
• University of California at San Francisco criteria can be applied to living donor liver transplantation for hepatocellular carcinoma: single-center preliminary results in 27 patients (Q46492375) (← links)
• Liberal policy in living donor liver transplantation for hepatocellular carcinoma: lessons learned. (Q50126990) (← links)
• Liver transplantation in the setting of hepatocellular carcinoma and portal vein thrombosis: a challenging dilemma? (Q50878935) (← links)
• Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. (Q53284674) (← links)
• Intraoperative abortion of adult living donor liver transplantation: 15 cases from 1,179 cases in 20 years of experience in a single center (Q57485482) (← links)
• Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison (Q58541779) (← links)
• Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: results and outcomes in 56 patients (Q73400013) (← links)
• Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis (Q75448369) (← links)
• Liver transplantation for hepatocellular carcinoma: a single European centre experience (Q76383775) (← links)
• Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation (Q79074915) (← links)
• [Living donor liver transplantation] (Q79268958) (← links)
• [Hepatic transplantation for hepatocellular carcinoma: state of the art] (Q80558795) (← links)
• Management of hepatocellular carcinoma (Q83816502) (← links)
• Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center (Q83937665) (← links)
• Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma (Q89953527) (← links)
• Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers (Q93184513) (← links)